January 31, 2019
Windows of Opportunity, performance 2016 to present, Biotech fund flows since 2017, CBOE volatility, performance by company in our universe.
Esther Hong, Paul Knight and Yun Zhong July 31, 2018
Notes from Biotechnology Research Analyst Esther Hong, JD; Notes from Specialty Pharmaceuticals Research Analyst Ken Trbovich, CFA; Notes from Life Sciences Technology Research Analyst Paul Knight, CFA; Notes from Biotechnology Analyst Yun Zhong, PhD
To learn about the professional background, business practices, and conduct of FINRA member firms or their financial professionals, visit FINRA’s BrokerCheck website: http://brokercheck.finra.org/